Monday, August 18, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Stellantis Secures Approval for Joint Venture with Leapmotor Propelling Global Expansion of Electric Vehicles

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Automotive Stock Market Today
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Stellantis secures approval from Chinese regulator NDRC for joint venture with Leapmotor, allowing for global expansion of electric vehicles.

This milestone agreement, following a $1.6 billion stake acquisition, grants Stellantis exclusive rights to manufacture, export, and sell Leapmotor products worldwide.

Amidst tensions between China and the EU over EV subsidies, Stellantis’ strategic move positions the company for success in the global EV market.

Stellantis’ shares (NYSE: STLA) saw a 1.81% increase to $27.28 post-approval, signaling investor confidence in the joint venture’s potential.

With access to Leapmotor’s technology and expertise, Stellantis is poised to drive innovation and market expansion beyond China.

Stellantis (STLA) Stock Soars: A Look at the Companys Strong Performance on March 6, 2024

On March 6, 2024, Stellantis (STLA) stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of STLA shares increased by $0.37 since the market last closed, representing a 1.38% rise.

Stellantis, formed through the merger of Fiat Chrysler Automobiles and PSA Group, has been making waves in the automotive industry with its innovative electric vehicles and commitment to sustainability. The company’s strong performance on March 6 reflects investor confidence in its growth potential and ability to navigate challenges in the market.

STLA Stock Performance Analysis: Mixed Results on March 6, 2024

On March 6, 2024, STLA stock had an interesting performance based on the financial data provided by CNN Money. The company’s total revenue for the past year was $98.81 billion, which is a significant decrease of 18.4% compared to the previous year. However, there was a positive trend in the last quarter as the total revenue increased by 12.96%.

Similarly, the net income for the past year was $33.06 million, showing a drastic decrease of 98.96% compared to the previous year. On a positive note, the net income for the last quarter was $1.86 billion, representing a 33.25% increase from the previous quarter.

Earnings per share (EPS) for the past year was $0.02, reflecting a significant decrease of 98.97% compared to the previous year. However, there was a slight improvement in the last quarter as the EPS increased by 5.33%.

Overall, the financial performance of STLA stock on March 6, 2024, showed mixed results. While there were significant declines in total revenue, net income, and EPS compared to the previous year, there were positive trends in the last quarter. Investors should closely monitor the company’s financial performance in the coming quarters to assess its long-term growth prospects.

Tags: STLA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (3)

New York Community Bancorp Faces Crisis Stock Plummets and Leadership Changes Shake Investor Confidence

Technology Artificial intelligence Market Capitalization

AWS and Nvidia Collaboration Revolutionizing AI Infrastructure and Services

Finance_Investment (5)

Goldman Sachs Reaffirms Buy Rating for Gossamer Bio with Revised Price Target

Recommended

Insider Activity at Minerals Technologies Raises Questions about Stock Options

2 years ago
Pharmaceutical Markets and money

Gilead Sciences Inc Completes Waiting Period for Tender Offer for CymaBay Therapeutics Inc

1 year ago
Technology Blockchain Markets and money

Analyst Ratings and Price Targets for KLA NASDAQ KLAC

2 years ago
Finance_Credit

Trustco Bank Declares Quarterly Dividend of 36 Cents per Share

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Danaher Stock: Market Experts Divided Amid Earnings Volatility

Institutional Investors Double Down on Ares Capital Despite Earnings Shortfall

Synopsys Stock: Diverging Signals Between Executives and Analysts

Biotech Stock Assembly Biosciences Gains Analyst Backing with $50 Price Target

Could Siemens Healthineers Emerge as the Dark Horse of Medical AI Innovation?

Geely Emerges as China’s Silent Contender in the EV Race

Trending

Axsome Stock
Stocks

Axsome Therapeutics Emerges as a High-Growth Contender in Neurological Drug Development

by Robert Sasse
August 18, 2025
0

Axsome Therapeutics is making waves in the biopharmaceutical sector with its groundbreaking treatments for some of neurology's...

Norfolk Southern Stock

Norfolk Southern Stock Gains Analyst Confidence Amid Operational Challenges

August 18, 2025
Newmont Mining Stock

Institutional Investors Divided on Newmont Mining as Gold Demand Surges

August 18, 2025
Danaher Stock

Danaher Stock: Market Experts Divided Amid Earnings Volatility

August 18, 2025
Ares Capital Stock

Institutional Investors Double Down on Ares Capital Despite Earnings Shortfall

August 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Axsome Therapeutics Emerges as a High-Growth Contender in Neurological Drug Development August 18, 2025
  • Norfolk Southern Stock Gains Analyst Confidence Amid Operational Challenges August 18, 2025
  • Institutional Investors Divided on Newmont Mining as Gold Demand Surges August 18, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com